Matrix metalloproteinase 3 deletion preserves denervated motor endplates after traumatic nerve injury

Ann Neurol. 2013 Feb;73(2):210-23. doi: 10.1002/ana.23781. Epub 2012 Dec 31.

Abstract

Objective: Traumatic peripheral nerve injuries often produce permanent functional deficits despite optimal surgical and medical management. One reason for the impaired target organ reinnervation is degradation of motor endplates during prolonged denervation. Here we investigate the effect of preserving agrin on the stability of denervated endplates. Because matrix metalloproteinase 3 (MMP3) is known to degrade agrin, we examined the changes in endplate structure following traumatic nerve injury in MMP3 knockout mice.

Methods: After creation of a critical size nerve defect to preclude reinnervation, we characterized receptor area, receptor density, and endplate morphology in denervated plantaris muscles in wild-type and MMP3 null mice. The level of agrin and muscle-specific kinase (MuSK) was assessed at denervated endplates. In addition, denervated muscles were subjected to ex vivo stimulation with acetylcholine. Finally, reinnervation potential was compared after long-term denervation.

Results: In wild-type mice, the endplates demonstrated time-dependent decreases in area and receptor density and conversion to an immature receptor phenotype. In striking contrast, all denervation-induced changes were attenuated in MMP3 null mice, with endplates retaining their differentiated form. Agrin and MuSK were preserved in endplates from denervated MMP3 null animals. Furthermore, denervated muscles from MMP3 null mice demonstrated greater endplate efficacy and reinnervation.

Interpretation: These results demonstrate a critical role for MMP3 in motor endplate remodeling, and reveal a potential target for therapeutic intervention to prevent motor endplate degradation following nerve injury.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholine / pharmacology
  • Agrin / metabolism
  • Animals
  • Cell Line
  • Cholinergic Agonists / pharmacology
  • Disease Models, Animal
  • Gene Deletion
  • Male
  • Matrix Metalloproteinase 3 / genetics*
  • Matrix Metalloproteinase 3 / metabolism*
  • Mice
  • Mice, 129 Strain
  • Mice, Knockout
  • Motor Activity / physiology
  • Motor Endplate / drug effects
  • Motor Endplate / enzymology*
  • Muscle Denervation / methods
  • Muscle, Skeletal / drug effects
  • Muscle, Skeletal / innervation
  • Muscle, Skeletal / pathology
  • Muscular Atrophy / metabolism
  • Muscular Atrophy / physiopathology
  • Nerve Regeneration / physiology*
  • Peripheral Nerve Injuries / metabolism*
  • Peripheral Nerve Injuries / physiopathology*
  • Receptor Protein-Tyrosine Kinases / metabolism
  • Receptors, Cholinergic / metabolism
  • Wallerian Degeneration / metabolism
  • Wallerian Degeneration / physiopathology

Substances

  • Agrin
  • Cholinergic Agonists
  • Receptors, Cholinergic
  • MuSK protein, mouse
  • Receptor Protein-Tyrosine Kinases
  • Matrix Metalloproteinase 3
  • Mmp3 protein, mouse
  • Acetylcholine